Ignite Creation Date:
2024-05-05 @ 11:56 AM
Last Modification Date:
2024-10-26 @ 9:16 AM
Study NCT ID:
NCT00181532
Status:
COMPLETED
Last Update Posted:
2009-06-30
First Post:
2005-09-13
Brief Title:
Phase II Study of Celecoxib and Concurrent Radiotherapy in Stage II-III NSCLC
Sponsor:
Maastricht Radiation Oncology
Organization:
Maastricht Radiation Oncology
Organization Data
Organization:
Maastricht Radiation Oncology
Class:
OTHER
Study ID:
P021376L
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Maastricht Radiation Oncology
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Pfizer | INDUSTRY |